Remedica is specialised in the development and supply of pharmaceutical products for out-licensing. It offers attractive out-licensing opportunities to companies throughout the globe in a wide range of therapeutic areas. The offered dossiers comply with all applicable international and European standards. Together with you, Remedica will work towards the most cost effective solution aiming to be a sustainable partner that offers tailored solutions according to your specific needs and requirements.
GENERIC NAME | STRENGTH & DOSAGE FORM | THERAPEUTIC CATEGORY | MAIN CATEGORY | DOSSIER AVAILABILITY |
---|---|---|---|---|
ABACAVIR / LAMIVUDINE** | 600mg/300mg Film-coated tablets | Antivirals | Systemic antiinfectives | YES |
ABIRATERONE ACETATE** | 250mg and 500mg Film-coated tablets | Antineoplastic agents | Endocrine | YES |
ACETYLSALICYLIC ACID | 75mg Gastro-resistant tablets | Antithrombotic agents | Blood and Blood forming organs | Q3-2025 |
ACICLOVIR | 200mg, 400mg, 800mg Tablets | Antivirals | Systemic antiinfectives | Q4-2024 |
ALBENDAZOLE | 400mg Tablets | Anthelmintics | Antiparasitic | YES |
ALLOPURINOL | 100mg, 300mg Tablets | Antigout | Musculo-skeletal | Q3-2023 |
AMIODARONE | 200mg Tablets | Antiarrhythmics | Cardiovascular | Q1-2025 |
AMITRIPTYLINE | 10mg, 25mg Film-coated tablets | Antidepressants | Nervous system | Q4-2023 |
AMOXICILLIN | 125mg, 250mg, 500mg Dispersible Tablets | Antibacterials | Systemic antiinfectives | Q2-2023 |
AMOXICILLIN | 250mg, 500mg Capsules, hard | Antibacterials | Systemic antiinfectives | YES |
AMOXICILLIN | 125mg/5ml, 250mg/5ml Powder for oral suspension | Antibacterials | Systemic antiinfectives | Q1-2025 |
AMOXICILLIN / CLAVULANIC ACID | 875/125mg Film-coated Tablets | Antibacterials | Systemic antiinfectives | Q4-2024 |
AMOXICILLIN / CLAVULANIC ACID | 500mg/125mg Film-coated tablets | Antibacterials | Systemic antiinfectives | Q4-2023 |
ANASTROZOLE ** | 1mg Film-coated tablets | Antineoplastic agents | Endocrine | YES |
APIXABAN ** | 2.5mg, 5mg Film-coated tablets | Antithrombotic agents | Blood and Blood forming organs | Q4-2024 |
ARTEMETHER / LUMEFANTRINE | 20/120mg Tablets | Antimalarials | Antiparasitic | Q4-2024 |
ARTESUNATE / AMODIAQUINE | 25mg / 67.5mg, 50mg / 135mg, 100mg / 270mg, Tablets | Antimalarials | Antiparasitic | Q2-2025 |
ATAZANAVIR ** | 100mg, 150mg, 200mg, 300mg Capsules, hard | Antivirals | Systemic antiinfectives | YES |
AZATHIOPRINE | 50mg Film-coated tablets | Immunosuppressants | Immune system | Q4-2022 |
AZITHROMYCIN | 125mg, 250mg, 500mg Film-coated tablets | Antibacterial | Systemic antiinfectives | Q1-2024 |
BISACODYL | 5mg Gastro-resistant tablets | Laxatives | Alimentary tract and Metabollism | Q3-2023 |
BROMAZEPAM | 1.5mg, 3mg, 6mg Tablets | Anxiolytics | Nervous system | Q3-2024 |
CALCIUM LACTATE PENTAHYDRATE | 300mg Tablets | Supplements | Alimentary tract and Metabollism | YES |
CAPECITABINE ** | 150mg, 500mg Film-coated tablets | Antineoplastic agents | Antimetabolites | YES |
CARBAMAZEPINE | 200mg Tablets | Antiepileptics | Nervous system | Q4-2022 |
CARBAMAZEPINE | 400mg Prolonged-release tablets | Antiepileptics | Nervous system | Q4-2023 |
CARBIMAZOLE | 5mg Tablets | Antithyroid agents | Thyroid therapy | Q3-2023 |
CEFALEXIN | 250mg, 500mg Capsules, hard | Antibacterials | Systemic antiinfectives | Q1-2023 |
CEFIXIME | 200mg, 400mg Film-coated tablets | Antibacterials | Systemic antiinfectives | Q4-2023 |
CEFPODOXIME PROXETIL | 100mg, 200mg Film-coated tablets | Antibacterials | Systemic antiinfectives | Q1-2024 |
CEFUROXIME | 125mg, 250mg, 500mg Film-coated tablets | Antibacterial | Systemic antiinfectives | Q1-2024 |
CHLORDIAZEPOXIDE / CLINIDIUM BROMIDE | 5mg/2.5mg Coated tablets | Gastrointestinal disorders drugs | Alimentary tract and Metabollism | Q3-2024 |
CHLORPROMAZINE | 25mg, 50mg,100mg Film-coated tablets | Antipsychotics | Nervous system | Q4-2023 |
CIPROFLOXACIN | 250mg, 500mg, 750mg Film-coated tablets | Antibacterials | Systemic antiinfectives | Q1-2023 |
CLARITHROMYCIN | 250mg, 500mg Film-coated tablets | Antibacterials | Systemic antiinfectives | YES |
CLONAZEPAM | 0.5mg, 2mg Tablets | Antiepileptics | Nervous system | Q4-2023 |
CLOZAPINE | 25mg, 100mg Film-coated tablets | Antipsychotics | Nervous system | YES |
DAPOXETINE HYDROCHLORIDE | 30mg, 60mg Film-coated tablets | Other urologicals | Genito urinary system | Q3-2022 |
DARUNAVIR ** | 75mg, 150mg, 300mg, 400mg, 600mg, 800mg Film-coated tablets | Antivirals | Systemic antiinfectives | YES |
DASATINIB ** | 20mg, 50mg, 70mg, 80mg, 100mg, 140mg Film-coated tablets | Antineoplastic agents | Anti-cancer drugs | YES |
DIAZEPAM | 2mg, 5mg, 10mg Tablets | Anxiolytics | Nervous system | Q1-2025 |
DICLOFENAC SODIUM | 50mg Gastro-resistant tablets | Antiinflammatory | Musculo-skeletal | Q1-2023 |
DICLOFENAC SODIUM | 100mg Prolonged-release tablets | Antiinflammatory | Musculo-skeletal | Q4-2024 |
DONEPEZIL | 5MG, 10mg, Film-coated tablets | Anti-dementia agent | Nervous system | Q4-2024 |
DOXYCYCLINE | 100mg Film-coated tablets | Antibacterials | Systemic antiinfectives | Q4-2024 |
DOXYCYCLINE | 100mg Capsules, hard | Antibacterials | Systemic antiinfectives | Q4-2025 |
EFAVIRENZ / EMTRICITABINE / TENOFOVIR DISOPROXIL ** | 600mg/200mg/245mg Film-coated tablets | Antivirals | Systemic antiinfectives | YES |
EMTRICITABINE / TENOFOVIR DISOPROXIL ** | 200mg/245mg Film-coated tablets | Antivirals | Systemic antiinfectives | YES |
ENALAPRIL MALEATE | 5mg, 10mg, 20mg Tablets | ACE inhibitors | Cardiovascular | YES |
ENTECAVIR ** | 0.5mg, 1mg Film-coated tablets | Antivirals | Systemic antiinfectives | YES |
ERLOTINIB ** | 25mg, 50mg, 100mg, 150mg Film-coated tablets | Antineoplastic agents | Anti-cancer drugs | YES |
ERYTHROMYCIN | 125mg/5ml, 250mg/5ml Powder for oral suspension | Antibacterials | Systemic antiinfectives | Q1-2024 |
ERYTHROMYCIN | 250mg, 500mg Film-coated tablets | Antibacterials | Systemic antiinfectives | Q1-2025 |
ESCITALOPRAM | 5mg, 10mg, 20mg Film-coated tablets | Antidepressants | Nervous system | Q1-2024 |
EXEMESTANE | 25mg Film-coated tablets | Antineoplastic agents | Endocrine | YES |
FAMOTIDINE | 20mg, 40mg Film-coated tablets | Antiulcerants & antireflux agents | Alimentary tract and Metabollism | Q3-2023 |
FERROUS FUMARATE | 200mg Film-coated tablets | Antianemic preparations | Blood and Blood forming organs | Q2-2023 |
FERROUS FUMARATE / FOLIC ACID | 185mg/0.4mg, 310mg/0.35mg Film-coated tablets | Antianemic preparations | Blood and Blood forming organs | Q4-2023 |
FEXOFENADINE | 120mg, 180mg Tablets | Antihistamines | Respiratory | Q3-2024 |
FINGOLIMOD** | 0.5mg Capsules, hard | Immunosuppressants | Immune system | YES |
FUROSEMIDE | 40mg Tablets | Diuretics | Cardiovascular | Q1-2025 |
GEFITINIB ** | 250mg Film-coated tablets | Antineoplastic agents | Anti-cancer drugs | YES |
HYDRALAZINE | 25mg Film-coated tablets | Antihypertensives | Cardiovascular | Q3-2023 |
HYOSCINE BUTYLBROMIDE | 10mg Coated tablets | Gastrointestinal disorder drugs | Alimentary tract and Metabollism | Q4-2023 |
IBUPROFEN | 200mg, 400mg, 600mg Film-coated tablets | Antiinflammatory & antirheumatics | Musculo-skeletal | YES |
IMATINIB ** | 100mg, 400mg Film-coated tablets | Antineoplastic agents | Anti-cancer drugs | YES |
IVABRADINE ** | 5mg, 7.5mg Film-coated tablets | Antiischemic preparation | Cardiovascular | YES |
LAPATINIB ** | 250mg Film-coated tablets | Antineoplastic agents | Anti-cancer drugs | YES |
LETROZOLE | 2.5mg Film-coated tablets | Antineoplastic agents | Endocrine | Q3-2022 |
LEVETIRACETAM ** | 250mg, 500mg, 750mg, 1000mg Film-coated tablets | Antiepileptics | Nervous system | YES |
LEVETIRACETAM ** | 100mg/ml Oral solution | Antiepileptics | Nervous system | YES |
LEVODOPA / CARBIDOPA | 250mg/25mg, 100mg/25mg, 100mg/10mg Tablets | Antiparkinsons drugs | Nervous system | Q1-2023 |
LINAGLIPTIN / METFORMIN ** | 2.5mg/850mg, 2.5mg/1000mg Film-Coated Tablets | Diabetes drugs | Alimentary tract and Metabollism | Q2-2024 |
LINAGLIPTIN** | 5mg Film-Coated Tablets | Diabetes drugs | Alimentary tract and Metabollism | Q3-2024 |
METFORMIN HYDROCHLORIDE | 500mg, 850mg Film-coated tablets | Diabetes drugs | Alimentary tract and Metabollism | Q3-2023 |
METHOTREXATE | 2.5 mg Film-coated tablets | Antineoplastic agents | Antimetabolites | YES |
METHYLDOPA | 250 mg Film-coated tablets | Antihypertensives | Cardiovascular | Q3-2023 |
METRONIDAZOLE | 200mg, 250mg, 400mg, 500mg Film-coated tablets | Antibacterials | Systemic antiinfectives | Q1-2025 |
NAPROXEN | 250mg, 500mg Tablets | Antiinflammatory & antirheumatics | Musculo-skeletal | Q1-2023 |
NIFEDIPINE | 10mg Film-coated tablets | Calcium channel blockers | Cardiovascular | Q3-2026 |
NIFEDIPINE | 20mg Prolonged-release tablets | Calcium channel blockers | Cardiovascular | Q3-2025 |
NORETHISTERONE | 5mg Tablets | Sex hormones and modulators of the genital system | Genito urinary system | Q4-2023 |
PAZOPANIB (as hydrochloride) ** | 200mg, 400mg Film-coated tablets | Antineoplastic agents | Anti-cancer drugs | YES |
PHENOXYMETHYLPENICILLIN | 800mg, 1000mg Film-coated tablets | Antibacterials | Systemic antiinfectives | YES |
PREGABALIN | 25mg, 75mg, 150mg, 300mg Capsules, hard | Antiepileptics | Nervous system | Q3-2022 |
PRIMAQUINE (as Diphosphate) | 7.5 mg, 15 mg Film-coated tablets | Antimalarials | Antiparasitic | Q3-2022 |
QUININE SULPHATE | 300mg Film-coated tablets | Antimalarials | Antiparasitic | Q3-2023 |
RASAGILINE ** | 1mg Tablets | Antiparkinsons drugs | Nervous system | YES |
RIFAXIMINE** | 200mg, 550mg Film-coated tablets | Antibacterials | Alimentary tract and Metabollism | Q2-2023 |
RIVAROXABAN | 2.5mg, 10mg, 15mg, 20mg Film-coated tablets | Antithrombotic agents | Blood and Blood forming organs | YES |
SILDENAFIL | 25mg, 50mg, 100mg Film-coated tablets | Erectile dysfunction agents | Genito urinary system | Q1-2023 |
SITAGLIPTIN (as Hydrochloride monohydrate)* | 25mg, 50mg, 100mg Film-coated tablets | Diabetes drugs | Alimentary tract and Metabollism | YES |
SITAGLIPTIN (as Hydrochloride monohydrate) / METFORMIN HYDROCHLORIDE* | 50mg/850mg, 50mg/1000mg Film-coated tablets | Diabetes drugs | Alimentary tract and Metabollism | YES |
SORAFENIB ** | 200mg Film-coated tablets | Antineoplastic agents | Anti-cancer drugs | YES |
SPIRONOLACTONE | 25mg, 50mg, 75mg, 100mg Film-coated tablets | Diuretics | Cardiovascular | Q4-2023 |
SULFADOXINE / PYRIMETHAMINE | 500mg/25 mg Tablets | Antimalarials | Antiparasitic | Q3-2023 |
SULPIRIDE | 50mg, 200mg Tablets | Antipsychotics | Nervous system | Q3-2023 |
SUMATRIPTAN | 50mg, 100mg Film-coated Tablets | Analgesics | Nervous system | Q1-2024 |
SUNITINIB ** | 12.5mg, 25mg, 37.5mg, 50mg Capsules, hard | Antineoplastic agents | Anti-cancer drugs | YES |
TAMOXIFEN | 10mg, 20mg Tablets | Antineoplastic agents | Endocrine | Q4-2023 |
TENOFOVIR DISOPROXIL ** | 123mg, 163mg, 204mg, 245mg Film-coated tablets | Antivirals | Systemic antiinfectives | YES |
TERBINAFINE | 250mg Tablets | Antifungals | Dermatologicals | YES |
TERIFLUNOMIDE** | 14mg Film-coated tablets | Immunosuppressants | Immune system | YES |
TICAGRELOR | 60mg, 90mg Film-coated tablets | Antithrombotic agents | Blood and Blood forming organs | Q3-2022 |
VERAPAMIL | 40mg, 80mg Coated tablets | Calcium channel blockers | Cardiovascular | Q2-2025 |
*Patent Information: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.
**Outlicensing to certain terrotories is subject to possible pre-existing Remedica’s contractual obligations with other parties.